STI Prevention Clinical Trial
Announcing a research study evaluating an investigational drug, EVO100, a hormone-free vaginal gel, for the prevention of chlamydia and/or gonorrhea infection in women who have been recently diagnosed with and treated for these sexually transmitted infections. There is no charge for the investigational study drug or study procedures. Participants’ health will be monitored closely.
You may qualify, if you:
You may be eligible to participate if you meet all of the following criteria:
• Are a healthy, sexually active female 18 years and older
• Have received a diagnosis of and may have received treatment for chlamydia and/or gonorrhea in the last 16 weeks
• Are not currently pregnant
• Are willing to use a female-controlled method of birth control